THE Spain will continue to vaccinate 60-65 year olds with vaccine against the new AstraZeneca coronavirus, before proceeding with its allocation to the next priority age group of 66-69, announced today the country’s Ministry of Health.
The ministry announced yesterday that it would limit the vaccine to citizens over the age of 60, after regulators linked it to a rare form of brain clot.
Prior to that, Spain provided the product to key service workers aged 18 to over 65 years.
The Spanish Ministry of Health said it would soon decide whether to give the second dose of the vaccine to people who have already given the first.
Covid-19 cases have been rising for several weeks in Spain, which has fully vaccinated 3.02 million people and administered 9.8 million doses.
Today, Spain recorded 9,901 new cases of Covid-19, bringing the total number of infections to 3.34 million, while the death toll rose by 142 to 76,179.
German pharmaceutical company builds AstraZeneca vaccine factory in Saxony-Anhalt
The construction of a factory where the AstraZeneca vaccine against Covid-19 will be produced was started by the German pharmaceutical company IDT-Biologika in the area of Dessau-Roslau, in Saxony-Anhalt.
According to the company, which is investing about 100m euros in expanding its facilities, production could begin in early 2023. In addition, a vaccine bottling plant will be set up and, as IDT announced, the project will be completed. in half the time than usual.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
